Septerna Inc. Share Price Today: Live Updates & Key Insights

Septerna Inc. share price today is $24.16, up -0.41%. The stock opened at $23.92 against the previous close of $24.28, with an intraday high of $24.305 and low of $23.9.

Septerna Inc. Share Price Chart

Septerna Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Septerna Inc. Share Price Performance

$24.16 -0.0041(-0.41%) SEPN at 23 Mar 2026 03:10 PM Biotechnology
Lowest Today 23.9
Highest Today 24.305
Today’s Open 23.92
Prev. Close 24.28
52 Week High 32.63
52 Week Low 4.66
Day’s Range: Low 23.9 High 24.305
52-Week Range: Low 4.66 High 32.63
1 day return -
1 Week return -3.65
1 month return -13.77
3 month return -17.95
6 month return +52.04
1 year return +280.51
3 year return -
5 year return -
10 year return -

Septerna Inc. Institutional Holdings

Septerna Inc. Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Septerna Inc. Fundamentals

Market Cap 1085.84 M

PB Ratio 2.8431

PE Ratio 0.0

Enterprise Value 718.37 M

Total Assets 596.19 M

Volume 489838

Septerna Inc. Company Financials

About Septerna Inc. & investment objective

Company Information Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.

Organisation Biotechnology

Employees 130

Industry Biotechnology

CEO Dr. Jeffrey T. Finer M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Septerna Inc. FAQs

What is the share price of Septerna Inc. today?

The current share price of Septerna Inc. is $24.16.

Can I buy Septerna Inc. shares in India?

Yes, Indian investors can buy Septerna Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Septerna Inc. shares in India?

You can easily invest in Septerna Inc. shares from India by:

Can I buy fractional shares of Septerna Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Septerna Inc.?

Septerna Inc. has a market cap of $1085.84 M.

In which sector does Septerna Inc. belong?

Septerna Inc. operates in the Biotechnology sector.

What documents are required to invest in Septerna Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Septerna Inc.?

The PE ratio of Septerna Inc. is N/A and the PB ratio is 2.84.